0001567619-22-002014.txt : 20220128
0001567619-22-002014.hdr.sgml : 20220128
20220128210255
ACCESSION NUMBER: 0001567619-22-002014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220126
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quirk Erin
CENTRAL INDEX KEY: 0001843038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39926
FILM NUMBER: 22570966
MAIL ADDRESS:
STREET 1: C/O TERNS PHARMACEUTICALS, INC.
STREET 2: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001831363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-525-5535 EXT.101
MAIL ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc1.xml
FORM 4
X0306
4
2022-01-26
0
0001831363
Terns Pharmaceuticals, Inc.
TERN
0001843038
Quirk Erin
C/O TERNS PHARMACEUTICALS, INC.
1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY
CA
94404
0
1
0
0
President, CMO and Head of R&D
Stock Option (Right to Buy)
5.36
2022-01-26
4
A
0
92500
0.00
A
2032-01-26
Common Stock
92500
92500
D
25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
/s/ Bryan Yoon, as Attorney-in-Fact for Erin Quirk
2022-01-28